US cancer specialist at centre of 6.5-bln-dlr takeover battle (AFP)

Posted by Admin on October 6, 2008 at 5:10 am · Under SCIENCE

US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).(ImClone)AFP - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).


More: continued here

Leave a Comment for US cancer specialist at centre of 6.5-bln-dlr takeover battle (AFP)